PDE5A and erectile dysfunction: Tadalafil, a phosphodiesterase type-5 (PDE-5) inhibitor widely used to treat erectile dysfunction, increases cyclic guanosine monophosphate (cGMP) levels and blood flow via cGMP’s vasoactive activity [10].